Helison Carvalho

Prof. Dr. Helison Carvalho

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Revista Brasileira de Farmacognosia
Verified
Journal Article
Open access
HSHeitor Ribeiro da Silva
Heitor Ribeiro da Silva
DADaniele da Cruz de Assis
Daniele da Cruz de Assis
APAriadna Lafourcade Prada
Ariadna Lafourcade Prada
JJJosé Otávio Silva Júnior
José Otávio Silva Júnior
MSMayara Brito de Sousa
Mayara Brito de Sousa
José Carlos Tavares CarvalhoJosé Carlos Tavares Carvalho
José Carlos Tavares Carvalho

14 September 2020 in Inflammopharmacology
Verified
Journal Article
Closed access
PDF file
Helison CarvalhoHelison Carvalho
Helison Carvalho
DGDanna Emanuelle Santos Gonçalves
Danna Emanuelle Santos Gonçalves
KPKaryny Roberta Tavares Picanço
Karyny Roberta Tavares Picanço
ASAbrahão Victor Tavares de Lima Teixeira dos Santos
Abrahão Victor Tavares de Lima Teixeira dos Santos
MLMaria Lucia
Maria Lucia
José Carlos Tavares CarvalhoJosé Carlos Tavares Carvalho
José Carlos Tavares Carvalho

4 August 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Arlindo César Matias PereiraArlindo César Matias Pereira
Arlindo César Matias Pereira
Helison CarvalhoHelison Carvalho
Helison Carvalho
DGDanna Emanuelle Santos Gonçalves
Danna Emanuelle Santos Gonçalves
KPKaryny Roberta Tavares Picanço
Karyny Roberta Tavares Picanço
ALAbrahão Victor Tavares de Lima
Abrahão Victor Tavares de Lima
José Carlos Tavares CarvalhoJosé Carlos Tavares Carvalho
José Carlos Tavares Carvalho
This study aimed to evaluate and compare the effects of co-treatment with purified annatto oil (PAO) or its granules (GRA, Chronic®) with that of testosterone on the orchiectomy-induced osteoporosis in Wistar rats. After surgery, rats were treated from day 7 until day 45 with testosterone only (TES, 7 mg/kg, IM) or TES + PAO or GRA (200 mg/kg, p.o.). The following parameters were evaluated: food/water intake, weight, HDL, LDL, glucose, triglycerides (TG), total cholesterol (TC), alkaline phosphatase levels, blood phosphorus and calcium contents, femur weight, structure (through scanning electron microscopy), and calcium content (through atomic absorption spectrophotometry). Our results show that orchiectomy could significantly change the blood lipid profile and decrease bone integrity parameters. Testosterone reposition alone could improve some endpoints, including LDL, TC, bone weight, and bone calcium concentration. However, other parameters were not significantly improved. Co-treatment with PAO or GRA improved the blood lipid profile and bone integrity more significantly and improved some endpoints not affected by testosterone reposition alone (such as TG levels and trabeculae sizes). The results suggest that co-treatment with annatto products improved the blood lipid profile and the anti-osteoporosis effects of testosterone. Overall, GRA had better results than PAO.

28 February 2023 in Inflammopharmacology
Verified
Journal Article
Closed access
PDF file
Helison CarvalhoHelison Carvalho
Helison Carvalho
ASAna Laura Ribeiro Sauma
Ana Laura Ribeiro Sauma
ANAline Lopes Do Nascimento
Aline Lopes Do Nascimento
ATAbrahão Victor Tavares de Lima Teixeira
Abrahão Victor Tavares de Lima Teixeira
DGDanna Emanuelle Santos Gonçalves
Danna Emanuelle Santos Gonçalves
José Carlos Tavares CarvalhoJosé Carlos Tavares Carvalho
José Carlos Tavares Carvalho

19 November 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
CRClarice Flexa da Rocha
Clarice Flexa da Rocha
CFCamila de Nazaré Nunes Flexa
Camila de Nazaré Nunes Flexa
GSGisele Custódio de Souza
Gisele Custódio de Souza
Arlindo César Matias PereiraArlindo César Matias Pereira
Arlindo César Matias Pereira
Helison CarvalhoHelison Carvalho
Helison Carvalho
José Carlos Tavares CarvalhoJosé Carlos Tavares Carvalho
José Carlos Tavares Carvalho
The zebrafish is a popular organism to test the toxicity of compounds. Here, we evaluate the acute and reproductive toxicity of Ormona SI® (OSI) and RC® (ORC), two herbal products developed for menopausal women with tocotrienols, geranylgeraniol, isoflavones, and anthocyanins. The acute toxicity was evaluated by behavioral alterations, lethality, and tissue changes (intestine, liver, kidney) after oral treatment with high product doses (500, 1000, and 2000 mg/kg). The reproductive toxicity was evaluated after 21 days of oral treatment with OSI and ORC at 200 mg/kg. Our results show that the LD50 could not be assessed due to the low mortality rate even with the highest dose; the behavioral alterations were not different from those of the group treated only with the vehicle (2% DMSO). The tissue changes were minor in OSI and more severe in ORC at the highest (2000 mg/kg) dose, while no tissue abnormality was observed at 500 mg/kg. In the reproductive assessment, continuous treatment could decrease the maturation of the reproductive cells, which also significantly decreases the egg spawning. This effect was attributed to the estrogenic activity of the isoflavones. In conclusion, the acute toxicity analysis shows that the products did not elicit lethal or sublethal effects observed in the model when used up to 500 mg/kg. Regarding the reproductive toxicity, decreased fertility was observed, which was expected due to the presence of isoflavones (phytoestrogens). Considering that the product is intended for menopausal and postmenopausal women, the presence of isoflavones is beneficial. Further studies should be performed to corroborate these results in mammals.

19 September 2023 in Molecules
Verified
Journal Article
Open access
PDF file
PSPRISCILA FAIMANN SALES
PRISCILA FAIMANN SALES
ANAline Lopes Do Nascimento
Aline Lopes Do Nascimento
FPFernanda Cavalcante Pinheiro
Fernanda Cavalcante Pinheiro
AAAndressa Ketelem Meireles Alberto
Andressa Ketelem Meireles Alberto
ALAbrahão Victor Tavares de Lima
Abrahão Victor Tavares de Lima
José Carlos Tavares CarvalhoJosé Carlos Tavares Carvalho
José Carlos Tavares Carvalho
Dyslipidemia presents high levels of serum cholesterol and is characterized as a risk factor for cardiovascular diseases, especially for the development of atherosclerosis. E. oleracea oil (OFEO), A. esculentus oil (OFAE), B. orellana oil (OFBO), and Chronic SM® granules (CHR) are rich in bioactive compounds with the potential to treat changes in lipid metabolism. This study investigated the effects of treatments with oils from A. esculentus, E. oleracea, B. orellana, and Chronic SM® on Cocos nucifera L. saturated-fat-induced dyslipidemia. The chromatographic profile showed the majority presence of unsaturated fatty acids in the tested oils. The quantification of tocotrienols and geranylgeraniol in OFBO and CHR was obtained. Treatments with OFEO, OFAE, OFBO, and CHR were able to significantly reduce glycemia, as well as hypertriglyceridemia, total cholesterol, and LDL-cholesterol, besides increasing HDL-cholesterol. The treatments inhibited the formation of atheromatous plaques in the vascular endothelium of the treated rats. The obtained results suggest that the OFEO, OFAE, OFBO, and CHR exhibit antidyslipidemic effects and antiatherogenic activity.